跳至主要内容
临床试验/ITMCTR2200005870
ITMCTR2200005870尚未招募未知

Real-world effect of traditional Chinese medicine combined with secukinumab in patients with psoriasis:protocol of a multi-center cohort study

Beijing Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
18 至 —(—)
性别
All

入选标准

  • (1) Age = 18 years old.
  • (2) Patients with moderate to severe chronic plaque psoriasis for at least 6 months.
  • (3) Patients were inadequately controlled by topical treatments, phototherapy, and/or previous systemic therapy.
  • (4) The disease was moderate to severe, psoriasis area severity index [PASI] =12, Investigators Global Assessment [IGA] score =3, and body surface area [BSA]involvement =10%.
  • (5) The diagnostic criteria of TCM syndromes accord with psoriasis blood heat syndrome, blood dryness syndrome or blood stasis syndrome.
  • (6) Signed the informed consent form, and the sign process complied with the provisions of GCP.
  • Those who meet all of the above six conditions at the same time are selected.

排除标准

  • (1) criteria included forms of psoriasis other than chronic plaque-type psoriasis, drug-induced psoriasis.
  • (2) Previous use of biological agents (including TNFaInhibitor, IL12/23 inhibitor or IL-17A inhibitor, etc.).
  • (3) Patients who are participating in clinical trials of other drugs.

研究者

相似试验